Dr. Temitope Ojo joined the Department of Medicine in the Division of Infectious Diseases as an Assistant Professor in July of 2025. She graduated from the New York University School of Global Public Health with a PhD in Public Health. She has authored several publications on global implementation research, including developing situationally tailored tools to assess relevant implementation outcomes in diverse settings. She also received her Bachelor of Arts in Biochemistry from Mount Holyoke College and her Masters in Public Health in Chronic Disease Epidemiology from Yale School of Public Health. She is a highly skilled and accomplished public health professional with significant research expertise in implementation science and noncommunicable disease epidemiology, particularly in the areas of cardiovascular and chronic kidney diseases.
She is a Research track Assistant Professor of Medicine and a co-Associate Director of the Light Institute for Global Health Transformation in the Infectious Diseases Division at WashU Medicine. In this role, Dr. Ojo oversees an 8-figure global and local public health program portfolio with a 16-person core team – providing strategic visioning, end-to-end implementation management, and organizational governance. Her research aims to identify and leverage social connections in designing implementation strategies that promote the equitable and sustained uptake of evidence-based interventions (EBIs) among adolescents and young adults (AYA), girls, women, communities, and low-resource settings. She uses Implementation Science (IS) and participatory action research to examine how partnerships, co-design, co-learning, and participatory approaches, including crowdsourcing, can address critical knowledge and implementation gaps in the adoption of EBIs.
Before joining WashU Medicine, Dr. Ojo worked as a management consultant at Boston Consulting Group, where she has a proven record of accomplishment in healthcare strategy and health equity projects. Her work involved enhancing oncology assets with a focus on equitable patient access in the biopharma space, a business development project to enhance market reach to low-income countries, and pitching an AI-powered tool to improve clinical trial diversity in the United States. From 2019 to 2022, she was the Lead of the Advancing the Science of Implementation in Global Settings (ASI) Section of the thriving NYU Implementation Science Lab – Implementing Sustainable Evidence-based Interventions through Engagement (ISEE) Lab – that she co-founded. With over a decade of experience in public health, clinical, and implementation research, consulting, and strategy roles, Dr. Ojo is passionate about driving pragmatic healthcare solutions that create lasting impact in global and local communities.
As a versatile and cross-functional collaborator, she has co-led public health programs focused on establishing and evaluating viability of prevention-to-treatment continuum for noncommunicable diseases, coordinated stakeholder engagement for multisite and multisectoral collaborations, and trained students and young researchers in foundational public health, and implementation science principles and applications, and in community-focused participatory research approaches. Her key interests are dissemination and implementation science, sustainability, participatory action research, community engagement, cancers, HIV/AIDS, women’s health, adolescent and young.